Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
Condition(s):Oligometastatic Disease; Liver Metastases; Colorectal CancerLast Updated:September 13, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Oligometastatic Disease; Liver Metastases; Colorectal CancerLast Updated:September 13, 2023Recruiting
Condition(s):Liver Metastasis Colon CancerLast Updated:December 22, 2023Recruiting
Condition(s):Hepatic MalignanciesLast Updated:March 5, 2024Recruiting
Condition(s):MRI; Liver Resection; Liver Failure as A Complication of CareLast Updated:November 29, 2023Recruiting
Condition(s):Liver Cirrhosis; Hepatocellular CarcinomaLast Updated:March 15, 2024Recruiting
Condition(s):Hepatocellular Carcinoma Stage IIILast Updated:November 18, 2021Not yet recruiting
Condition(s):Liver Cancer; Liver Cirrhoses; Liver CarcinomaLast Updated:May 12, 2023Recruiting
Condition(s):Colorectal Cancer; Liver MetastasesLast Updated:November 18, 2023Recruiting
Condition(s):Motor Function; Cognitive Function; Contrast MediaLast Updated:January 10, 2023Recruiting
Condition(s):PSCLast Updated:February 13, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.